The cocktail of drugs given to HIV patients has been dominated by Gilead Sciences (GILD) for over a decade. They are the...
U.S. biotech stocks are off to a strong start this week. It didn’t take long for investors to get over the Fed’s...
Vaccines have less efficacy with COVID-19 variants Key 3CL protease inhibitors shows promise for any COVID-19 variants, and potentially all coronav...
Aikido Pharma Inc. (NASDAQ: AIKI) announced excellent phase 1 data at the annual ASCO meeting. The data was presented by Dr. Scott...
Intel whitepaper highlights case study on Enzolytics COVID-19 and HIV potential for neutralization of both viruses. Bear case is nothing but FUD....
CytoDyn Inc (OTCMKTS: CYDY) shareholders got a real gut check yesterday as the STAT writer Adam Feuerstein sent out a tweet at...
The one OTC stock that needs to be on every investor’s radar right now is Regen BioPharma (OTCMKTS: RGBP). We alerted our...
For months, shareholders in Northwest Biotherapeutics (OTCMKTS: NWBO) have been speculating on the message boards about the timing of the release o...
Many CytoDyn Inc. (OTCMKTS: CYDY) shareholders have been waiting impatiently for an EUA from the US FDA and a BLA in HIV. ...
The ADHD market is over $10B yearly in the US. Last week, Kempharm (NASDAQ: KMPH) announced a very positive restructuring of their...